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Objective: To determine whether important racial, ethnic, or socioeconomic status (SES) health disparities exist
in infertility, impaired fecundity, or infertility treatment.
Design: Four waves of the National Survey of Family Growth (NSFG) were pooled. Measures were compared
across various race/ethnicity, education, and age groups.
Participant(s): Data for 31,047 women 15–44 years old from the NSFG were pooled.
Intervention(s): Outcomes were compared by whether the women’s states of residence had a mandate in place (at
least 1 year before the interview) to compel insurers to cover or offer to cover infertility treatment.
Main Outcome Measure(s): Infertility status, impaired fecundity, ever having sought infertility treatment.
Result(s): Infertility is more common for non-Hispanic black women, non-Hispanic other race women, and
Hispanic women than for non-Hispanic white women, and both infertility and impaired fecundity are more
common for high school dropouts and high school graduates with no college than for 4-year college graduates,
and for older women compared with women 29 and younger. Older women, non-Hispanic white women, and
women who are more educated (with at least some college) are more likely to have ever received treatment. No
evidence has been found that the racial, ethnic, or education disparities are ameliorated by the health insurance
mandates.
Conclusion(s): Racial, ethnic, and educational disparities exist in infertility status and treatment, and educational
disparities in impaired fecundity. More study of the impact of infertility treatment mandates on these disparities
is needed. (Fertil Steril 2006;85:858–65. ©2006 by American Society for Reproductive Medicine.)
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A large volume of research spanning the United States and
many other countries has demonstrated the existence of
racial, ethnic, and socioeconomic (SES) disparities in health
status, access to health care, and utilization of health care
services. One important area of reproductive health where
disparities have not been examined is infertility. Infertility
affects up to 10% of women of childbearing age (1), yet little
research has examined differentials in either the prevalence
of infertility or access to infertility treatment across different
racial, ethnic, or SES groups.
In some other countries, the public health insurance sys-
tem pays for some or all the costs of infertility treatment. In
the United States, however, the bulk of expenditures are
borne by the infertile couple, and many private insurance
policies do not cover infertility treatment. These treatments
can also be quite expensive, particularly when costs of
higher risk multiple births are included (2). A 1992 study
suggested that a successful birth after use of in vitro fertili-
zation (IVF) would have cost between $44,000 and $212,000
(3). Because of the expense of receiving treatment, higher
SES women receive the bulk of infertility treatments.
In response to concerns about the expense of infertility
treatment, 15 states have passed mandates compelling health
insurance companies to provide some form of infertility
beneﬁt. Additional states have ongoing legislative advocacy
efforts in this area, and similar bills have also been intro-
duced at the federal level. Given the continuing efforts to
expand coverage, it is important to understand how the effect
of these expansions may differ by race or SES.
This article uses pooled waves of the National Survey of
Family Growth spanning 1982–2002 to examine the preva-
lence of infertility and impaired fecundity, the use of infer-
tility treatment, and how infertility treatment is affected by
state laws mandating infertility insurance beneﬁts. We con-
trol for a series of individual and state level characteristics
known to inﬂuence fertility behavior and infertility, and then
interact our key variable—whether the woman’s state of
residence has an infertility mandate in place—with indica-
tors for race/ethnicity, educational attainment (our SES mea-
sure), and age.
Infertility and Impaired Fecundity in the United States
Demographers using the National Survey of Family Growth
have used two main deﬁnitions to classify whether women
are having difﬁculties in childbearing. Infertility is only
deﬁned for women who are currently married or cohabiting,
and is deﬁned for those women as the condition of being
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unprotected intercourse. Impaired fecundity, however, ap-
plies to women of any marital or cohabiting status. Those
who are nonsurgically sterile, who report having problems
conceiving or carrying a pregnancy to term, as well those
who are unable to conceive after 3 years of unprotected
intercourse fall into this category (1).
1 Potential problems
can be found with each of these deﬁnitions (see (5) for a
complete discussion). One major issue is that the trends in
these two deﬁnitions appear to be diverging in recent years.
Chandra and Stephen report that although the percentage of
women with impaired fecundity has increased signiﬁcantly
between 1988 and 2002, the percentage of women with
infertility has decreased signiﬁcantly (6).
Although a great deal of research has documented dispar-
ities in health status by race, ethnicity, and SES, less is
known about differentials in fertility and fecundity by these
factors. However, some evidence has been found that the
increase in impaired fecundity between 1982 and 1995 in the
United States occurred across almost all subgroups of
women, including along the dimensions of marital status,
income, education, race, and ethnicity (1).
Medical Assistance for Infertility/Impaired Fecundity
Of the 6.2 million women with impaired fecundity in 1995,
2.7 million (44%) had ever sought treatment (1). As a result
of the high (and often uninsured) costs associated with
treatment, however, medical assistance for infertility is
sought primarily by women and couples that are white,
college-educated, and afﬂuent. Women with private health
insurance coverage were 50% more likely to have received
services, as were women with income more than 300% of the
poverty line (7). It is widely believed that an unmet need
exists for infertility services, especially among those with
lower incomes and lower levels of education (8).
State Mandates to Insurers Regarding Infertility
Treatment
The ﬁrst state-level infertility insurance mandate was en-
acted by West Virginia in 1977. Since that time, 14 other
states have passed mandates, and additional states have
ongoing legislative advocacy efforts in this area. A mandate
“to cover” requires that health insurance companies provide
coverage of infertility treatment as a beneﬁt included in
every policy bought by ﬁrms. A mandate “to offer” requires
that health insurance companies make available to ﬁrms for
purchase a policy which offers coverage of infertility treat-
ment. In addition, some mandates cover all health plans,
whereas others either exclude health maintenance organiza-
tions (HMOs) or only cover HMOs. Finally, some mandates
exclude coverage of IVF, which is one of the most expensive
treatments available for infertility. Table 1 provides a list of
the states with mandates currently in place and the date the
mandates were enacted.
2
Using a differences-in-differences approach and Vital Sta-
tistics data for 1985–1999, Schmidt ﬁnds that the mandates
increase ﬁrst birth rates for all women 35 and older by 32%,
but ﬁnds no evidence of an effect of the mandates on the ﬁrst
birth rates of black women (10). Two other recent studies use
clinic data from 1998 and ﬁnd that states with required
coverage for IVF have the highest rates of IVF utilization
(11, 12). Hamilton and McManus develop a theoretical
model of the market for IVF and use data from clinics at the
Metropolitan Statistical Area level to test their model’s pre-
dictions (unpublished observation). Using data from 1995–
2000, they conﬁrm the ﬁndings reported in (11) and (12) that
a mandate increases IVF utilization rates. They also ﬁnd that
clinics are attracted to areas where women are more educated
and wealthier, but ﬁnd no evidence that clinics are attracted
to places where mandates are in effect.
Another recent study looks at the impacts of infertility
mandates on twin births and mixed-sex twin births (13),
ﬁnding that for women over 35, living in a mandate state is
associated with a statistically signiﬁcant increase in twin
1
We have modiﬁed the standard demographic deﬁnition to include the
non-surgically sterile as having impaired fecundity and the surgically
sterile as not having impaired fecundity. Recent work advocates using the
World Health Organization deﬁnition of trying to get pregnant for 24
months (4), however this measure is not available in our data.
2
Detailed information on these mandates, including any further restric-
tions placed on coverage, can be found in Schmidt (9)
TABLE 1
State-mandated infertility insurance.




















Note: Data come from Resolve (http://www.resolve.org)
and state laws (see Appendix A of Schmidt (9)).
a Arkansas, California, New York, and West Virginia
ﬁrst passed mandates in the years shown. These
mandates were subsequently revised, but remained
in place.
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(relative to same sex twins or singletons). Among twins,
being born to an older mother in a mandate state is associated
with being a lower birth weight, shorter gestation infant with
a lower Apgar score.
MATERIALS AND METHODS
We pooled data from the 1982, 1988, 1995, and 2002 cycles of
the National Survey of Family Growth (NSFG). The NSFG is
a periodic survey conducted by the National Center for Health
Statistics (NCHS), and surveys the civilian, noninstitutionalized
population of women 15–44 years old. The main purpose of the
survey is to provide reliable national data on marriage, divorce,
contraception, and the health of women and infants in the
United States. Most important for our analysis, the NSFG is the
only source of information over time about infertility, impaired
fecundity, and use of infertility treatment in the United States.
We use public-use data merged with state of residence identi-
ﬁers at NCHS’s Research Data Center. This allows us to link
our measure of access to infertility treatment—whether an
individual lived in a state that mandated coverage of infertility
treatment—to the individual-level data.
We also link other contextual measures such as state-level
demographics, labor market conditions, and public assistance gen-
erosity. For each woman, we link the nonmandate contextual
variables by the year in which her interview was completed. The
mandate variables are set to 1 if the mandate had been imple-
mented in the year before the woman was interviewed.
We ﬁrst present summary statistics for our key outcomes
of interest. Table 2 presents prevalence-type measures for
three variables: infertility (deﬁned as being unable to con-
ceive despite having had sex with the same partner for 12
months without contraception or pregnancy), impaired fe-
cundity (deﬁned as having trouble conceiving or carrying a
child to term, having been told by a doctor not to become
pregnant, having had sex for 36 months with the same
partner with no contraception or successful pregnancy, or
being noncontraceptively sterile), and having ever sought a
doctor’s help to become pregnant or avoid miscarriage.
3
3
These measures are complicated by the fact that for those women
classiﬁed as having fertility problems based on a ﬁxed time period of
unprotected sex, they can exit the state of infertility either by stopping
intercourse or by becoming pregnant. The treatment measure is the share
of women who report ever having sought treatment for infertility, a prev-
alence measure.
We also calculate the measures of infertility and impaired fecundity on
the sample of married women, to be consistent with earlier literature
using the NSFG. These latter two statistics are less straightforward prev-
alence measures, since the denominator is changing over time.
TABLE 2








Married now sample 0.077 0.178 —
Sex ever after menarche sample 0.047 0.151 0.145
Sample is divided by Married now Married now Sex ever
Race/ethnicity
White non-Hispanic 0.069 0.177 0.158
Black non-Hispanic 0.120 0.198 0.107
Other race non-Hispanic 0.100 0.182 0.128
Hispanic 0.092 0.171 0.115
Education level
High school dropout 0.099 0.210 0.099
High school graduate 0.082 0.183 0.144
Some college 0.066 0.176 0.155
College graduate 0.067 0.152 0.182
Maternal age
Age 29 or less 0.064 0.106 0.075
Age 30–34 0.080 0.166 0.185
Age 35–44 0.084 0.230 0.201
Note: Values are weighted means. Column 1 means are for 12-month infertility, column 2 for impaired fecundity, and
column 3 for ever having sought infertility treatment. Means in the top panel, ﬁrst row are for women age 15–44 who
are currently married; those in the top panel, second row are for women age 15–44 who ever had sex after menarche.
Means in the bottom panels (by race/ethnicity, education level, and age) are for the married now sample for column
1 (12-month infertility measure) and column 2 (impaired fecundity measure) but are for the sex ever after menarche
sample from column 3 (ever had infertility treatment).
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ples, the sample of all women 15–44 years old who have
ever had sex after menarche and the sample of married
women. The infertility treatment measure is given only for
women who have ever had sex after menarche.
4 The lower
panels of the table present means for all three measures by
race/ethnicity (upper middle panel), educational attainment
(lower middle panel), and age (lowest panel). In the lower
panels of Table 2, the sample for infertility and impaired
fecundity is women currently married, whereas the sample
for the infertility treatment measure is women having had
sex after menarche.
Several patterns are clear from Table 2. First, as would be
expected given the broader deﬁnition, the prevalence of
impaired fecundity is higher than the prevalence of infertil-
ity. Second, both infertility and impaired fecundity are more
common among non-white women, among less educated
women, and among older women (with the sole exception
that Hispanic women are less likely than white non-Hispanic
women to have impaired fecundity). However, use of treat-
ment is less common among non-white women and women
with lower levels of education, and much more common
among older women.
We then turn to multivariate logistic regressions, esti-
mated using Stata 9.1 (StataCorp LP, College Station, TX).
We ﬁrst examine racial, ethnic, and SES differences in
infertility status, impaired fecundity, and ever having sought
infertility treatment. We then consider whether living in a
state with an infertility mandate has differential effects by
race and ethnicity, SES (education), or age. We control for
other characteristics (age, demographic and economic char-
acteristics of the woman’s state of residence, state and year
ﬁxed effects). We weight the regressions to be population-
representative and adjust the standard errors for arbitrary
correlation within state-by-year cell and for heteroscedastic-
ity.
5
The regressions for the prevalence measure of ever having
had a visit for infertility treatment are run on the sample of
women ever having had sex after menarche. This prevalence
measure is asked of all women, and 7.9% of women who are
not currently married but have ever had sex after menarche
report having had such a visit. Thus, we would miss women
who have gotten treatment were we to restrict the treatment
regressions to the sample of women who were currently
married. The regressions for the measures of current infer-
tility status or impaired fecundity are run on the sample of
currently married women.
Approval to conduct this study was obtained from the
RAND Corporation’s Human Subjects Protection Commit-
tee, the Institutional Review Board.
RESULTS
Odds ratios from logistic regressions of the determinants of
12-month fertility can be found in column 1 of Table 3
(along with the marginal effect for the any infertility man-
date variable). As would be expected, age has a strong effect
on the probability of being infertile, with teenagers being the
least likely to experience infertility and the probability in-
creasing signiﬁcantly by age.
6 In addition, strong evidence
exists about the disparities by both race and SES (as proxied
for by educational attainment) in infertility. All non-white
racial and ethnic groups (black, other race, and Hispanic)
are signiﬁcantly more likely to experience infertility than
the omitted group of whites, and both high school drop-
outs and high school graduates are signiﬁcantly more
likely to experience infertility than four-year college grad-
uates.
Column 2 of Table 3 presents results from a similar
regression that looks at determinants of impaired fecundity.
In general, the patterns are similar for the two variables. Both
age and education have strong effects on the likelihood of
infertility and impaired fecundity. However, although the
odds ratios for blacks and other race women are both greater
than 1, these racial disparities in impaired fecundity are not
statistically signiﬁcant.
Several state-level variables also have a signiﬁcant effect
on fertility problems. The percent of the state population that
is Hispanic has a signiﬁcant negative effect on infertility
status that persists even after controlling for individual race/
ethnicity. Some evidence has also been found that after
controlling for race and SES, states that are better off ﬁnan-
cially are less likely to experience infertility: The percent of
the population below the federal poverty line has a positive and
signiﬁcant effect on infertility, but has no signiﬁcant effect on
impaired fecundity. No evidence has indicated that the state-
level mandates have an effect on the likelihood that a woman is
categorized with either infertility or impaired fecundity—the
odds ratio is close to 1 and insigniﬁcant.
4
Note that the lower panels of Table 2 and the regression results reported
in Table 3, Column 2 estimate the determinants of impaired fecundity for
only the sample of women married now to be comparable to the results
for infertility status.
5
The NSFG data are complex sample surveys. Our method of adjusting
the standard errors is as conservative as standard survey methods for our
estimates. Theoretically, this would be likely because the primary sam-
pling units (PSUs) or clusters for the NSFG data are typically counties or
MSAS, and are contained within states. Thus, allowing for arbitrary cor-
relations within state-by-year cell should lead to larger standard errors
than if we simply allowed such correlations within PSU, unless the error
term covaries negatively within state. Empirically, we have also estimated
our key regressions using one of Stata 9.1’s survey method estimators, a
version of logistic regression which adjusts the standard errors using
Taylor series linearization methods for both stratiﬁcation and clustering
within PSU.
These estimates are close to those reported in the paper. Because our
key mandate variable only varies at the state-by-year level, adjusting
variance estimates using survey methods still may overstate signiﬁcance.
The alternate survey method results are available on request.
6
Note that part of this age discrepancy is due to the fact that women who
are likely to delay childbearing are less likely to be married young and
thus less likely to appear in the sample while young but may appear while
older.
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that she has ever received infertility treatment. These results
are presented in column 3 and are for the sample of all
women who have had sex after menarche. Despite the evi-
dence of higher likelihoods of fertility problems by race,
ethnicity, and SES presented previously, women who are not
white and women who are of lower SES are signiﬁcantly less
likely to report ever having received infertility treatment.
Black women are 29% less likely to report ever having had
infertility treatment than white women, and similar racial
gaps exist (although slightly smaller in magnitude) for other
race and Hispanic women.
Similarly, there are large differentials in reports of treatment
by educational level. High school dropouts are 25% less likely
to report treatment than college graduates, and high school
graduates are 12% less likely to report treatment. No evidence
has indicated that state-level characteristics signiﬁcantly affect
access to infertility treatment once state ﬁxed effects are con-
trolled for with one exception: women in states with higher real
median income are signiﬁcantly more likely to report having
seen a doctor for infertility treatment. The odds ratio for the
mandate variable is not statistically signiﬁcant, suggesting that
the mandates do not signiﬁcantly affect the probability that a
woman has ever received treatment.
TABLE 3
Characteristics associated with infertility, impaired fecundity, and infertility treatment.
12-month infertility Impaired fecundity
Ever had infertility
treatment





















a (0.1539) 1.0939 (0.0781) 0.7069
a (0.0359)
Other race 1.4479
b (0.2424) 1.1110 (0.1359) 0.7683
b (0.0837)
Hispanic 1.2707
b (0.1506) 0.9101 (0.0793) 0.8095
b (0.0773)








Some college, no 4-year
degree
1.0125 (0.1108) 1.2659
a (0.0966) 0.9757 (0.0510)
Metropolitan statistical area 1.1397 (0.1002) 1.0683 (0.0685) 1.0682 (0.0633)
% Hispanic 0.9445
b (0.0273) 0.9939 (0.0196) 0.9769 (0.0187)
% black 0.9430 (0.0512) 0.9970 (0.0505) 0.9546 (0.0405)
Medicaid eligibility threshold 1.0013 (0.0011) 1.0001 (0.0008) 1.0006 (0.0008)
AFDC/TANF beneﬁts 1.0190 (0.0693) 1.0305 (0.0552) 0.9738 (0.0439)
Real median income 1.0338 (0.0233) 0.9968 (0.0145) 1.0284
c (0.0155)
Unemployment rate 0.0140 (0.0702) 0.2067 (0.5915) 7.4814 (21.414)
Employment growth rate 0.2228 (1.1668) 0.0467 (0.1349) 0.0755 (0.2270)
Share of population under FPL 269.85
c (798.84) 0.0383 (0.0768) 0.2757 (0.5083)
Share of births to unmarried
women
0.3739 (0.8694) 1.0907 (1.6820) 2.6688 (3.4323)
Marginal effect of any mandate 0.0001 (0.0089) 0.0124 (0.0155) 0.0001 (0.0098)
Number of observations 15,952 15,952 31,047
Log-likelihood 4213.22 7186.58 12,140.24
Pseudo R-squared 0.03 0.04 0.06
Note: Each column presents odds ratios from a separate logistic regression or, for the mandate variable, the marginal
effect. Regressions include state and year that ﬁxed effects and are weighted. Standard errors adjusted for arbitrary
correlation within state-by-year cell and heteroscedasticity. Levels of statistical signiﬁcance:
a denotes signiﬁcance at
the 1% level;
b at the 5% level; and
c at the 10% level. Signiﬁcance levels of odds ratios are from tests of logistic
regression coefﬁcients being zero. Marginal effect for any infertility mandate calculated for each observation and
averaged across the sample, with standard errors calculated by the delta method. AFDC  Aid to Families with
Dependent Children; TANF  Temporary Assistance to Needy Families; FPL  Federal Poverty Level.
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Any mandate 1.0011 (0.0821) 0.9457 (0.1062) 0.9286 (0.1097) 0.9627 (0.0859)
Age 30 or older — 2.5803
a (0.1401)
Any mandate  age 30 or older — 1.0924 (0.1008) — —
Some college or 4-year degree — — 1.1331
b (0.0663) —
Any mandate  some college
or 4-year degree
— — 1.1499 (0.1351) —
Non-white — — — 0.7141
a (0.0344)
Any mandate  non-white — — — 1.1585 (0.1337)
Marginal effects
Any mandate 0.0001 (0.0098) 0.0010 (0.0107) 0.0000 (0.0119) 0.0004 (0.0113)
Age 30 or older — 0.1087
a (0.0120) ——
Any mandate  age 30 or older — 0.0092 (0.0103) — —
Some college or 4-year degree — — 0.0194
b (0.0084) —
Any mandate  some college
or 4 year degree
— — 0.0165 (0.0136) —
Non-white — — — 0.0335
b (0.0080)
Any mandate  Non-white — — — 0.0161 (0.0131)
Log-likelihood 12,140.24 12,270.77 12,143.08 12,140.26
Pseudo R-squared 0.06 0.05 0.06 0.06
Note: Each column presents odds ratios from a separate logistic regression (top panel) or marginal effects (bottom panel). Regressions include state and year ﬁxed effects
as well as other controls in previous table not shown here and are weighted. Standard errors adjusted for arbitrary correlation within state-by-year cell and
heteroscedasticity. Levels of statistical signiﬁcance:
a denotes signiﬁcance at the 1% level; and
b at the 5% level. Signiﬁcance levels of odds ratios are from tests
of logistic regression coefﬁcients being zero. Marginal effects mandate calculated for each observation and averaged across the sample, with standard errors
calculated by the delta method.

























In Table 4, the regressions test whether the mandates have
differential effects for different groups of women. In column
1, we use the odds ratio from column 3 of Table 3 for
comparison. In column 2, the mandates are interacted with
an indicator for whether the woman is 30 or older, allowing
the mandate to have differential effects on older vs. younger
women. The top panel contains the odds ratios. Because the
model is nonlinear and the marginal effects depend on the
value of the various controls, however, it is necessary to
calculate marginal effects to assess whether the interaction is
signiﬁcant. The marginal effect is calculated for each obser-
vation and averaged across the sample, with standard errors
calculated by the delta method (14). These marginal effects
are presented in the lower panel of the table. The results
indicate no statistically signiﬁcant evidence of any age-
varying mandate effects.
In column 3, we allow for the mandates to have differen-
tial effects by SES (as proxied by educational level being
some college or a 4-year degree). The rhetoric surrounding
the push for mandated coverage of infertility treatment at
either the state or federal level often involves expanding
access to those groups who have been traditionally less
likely to receive treatment. However, our results in column 3
indicate no evidence of expanded access. Again, the mar-
ginal effects are reported in the bottom panel of the tables.
No evidence indicates that mandates increase the probability
of treatment for women with varying levels of education,
despite the strong statistical signiﬁcance of the main educa-
tion effect. Results in column 4 indicate similar patterns
when we interact the mandates with an indicator for whether
the woman is not white—again, no evidence indicates that
the mandates have expanded access to these groups. Inter-
estingly, a model with a three-way interaction between high
education, any mandate, and age at least 30 (along with all
the other two-way and one-way interactions) leads to a
marginal effect on the three-way interaction of 0.0464
(0.0227), which is signiﬁcant at the 5% level. This ﬁnding
also suggests that any impacts of the mandates in expanding
access are conﬁned to highly educated older women.
7 This is
consistent with the fact that private insurance coverage is
more common for this group of women.
DISCUSSION
We ﬁnd strong evidence of racial, ethnic, and SES disparities
in both infertility status and access to treatment. Hispanic
women and non-Hispanic black and other-race women, are
signiﬁcantly more likely to be infertile, but not signiﬁcantly
more likely to report impaired fecundity. One possible ex-
planation for this discrepancy is that the impaired fecundity
measure may be more subjective than the 12-month infertil-
ity measure. Although infertility is based on not becoming
pregnant during a 12-month period of unprotected inter-
course, one reason for being classiﬁed as impaired fecundity
is thinking that one would have difﬁculty getting pregnant or
carrying a pregnancy to term. This measure may be more
likely inﬂuenced by external factors.
High school dropouts and high school graduates are also
signiﬁcantly more likely to report both infertility and impaired
fecundity than their more highly educated counterparts. His-
panic women and non-Hispanic black and other-race women,
as well as less-educated women, are all signiﬁcantly less likely
to have ever sought medical treatment to get pregnant or to
prevent miscarriage.
However, we ﬁnd no signiﬁcant effects of the mandates on
use of treatment for the overall sample. One possible expla-
nation is due to the distinction between prevalence and
incidence. Conceptually, what we would ideally like to an-
alyze is the effect of a mandate on the probability that a
woman has treatment in a given year (i.e., the ﬂow of women
into the pool of the treated). The variable we are analyzing is
the stock of women who have ever received treatment. Even
if the mandates increase the number of women who receive
treatment in any given year, this increase may be small
enough relative to the stock of women who ever obtained
treatment that the estimated coefﬁcient may not be statisti-
cally signiﬁcant.
In addition, we ﬁnd no evidence that these mandates have
mitigated the disparities in treatment by race, ethnicity, or
SES (as proxied by education). These ﬁndings are consistent
with results from a survey done in Massachusetts, that sug-
gest that even in a state with a comprehensive mandate,
disparities in access to treatment exist along racial and SES
dimensions (15). In fact, our three-way interaction results
indicate a positive and statistically signiﬁcant marginal ef-
fect of the mandates on highly educated women over 30 and
older, which is additional evidence that despite the rhetoric
of expanded access accompanying passage of the mandates,
these laws may not be reducing existing disparities in treat-
ment. The results from the three-way interactions may not be
surprising given that highly educated women 30 and older
are also the group most likely to have private insurance.
Additional research is necessary to further explore why
mandates do not reduce these disparities. In addition, future
studies should investigate whether the mandates have af-
fected the timing of infertility visits or the types of diagnoses
and treatment obtained.
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